BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24237355)

  • 1. miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis.
    Sun Y; Shen S; Tang H; Xiang J; Peng Y; Tang A; Li N; Zhou W; Wang Z; Zhang D; Xiang B; Ge J; Li G; Wu M; Li X
    OMICS; 2014 Jan; 18(1):54-64. PubMed ID: 24237355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
    Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
    Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
    Chen E; Li Q; Wang H; Yang F; Min L; Yang J
    Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Wang X; Wang J; Ma H; Zhang J; Zhou X
    Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
    Wang N; Liu W
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Zhou T; Zhang G; Liu Z; Xia S; Tian H
    Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.
    Liu DR; Guan QL; Gao MT; Jiang L; Kang HX
    Med Sci Monit; 2016 Jul; 22():2417-23. PubMed ID: 27399918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
    Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
    Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
    Li L; Wang A; Cai M; Tong M; Chen F; Huang L
    Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.